What's breaking now, across thousands of outlets.
The drug developed by Novo, previously administered by injection in France, is now available in oral form, while the Danish manufacturer and its US competitor, Eli Lilly, are competing to establish themselves on a rapidly growing global market.
We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.
The death rate among confirmed Ebola cases in the Democratic Republic of Congo has climbed above 50% after health authorities added hundreds of previously unallocated fatalities to the official toll.
Onyebuchi Ezigbo in Abuja Minister of Budget and Economic Planning, Abubakar Atiku Bagudu, said the federal government has made huge investment in cancer detection machines and treatment procedures in…
Medical experts have raised concerns over increasing cases of sudden deaths among young people and the prevalence of prostate cancer among Nigerian men, urging Nigerians to prioritise regular health…
Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it the first company from the country to partner with the city’s government under a flagship investment initiative.
Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it the first company from the country to partner with the city’s government under a flagship investment initiative.
The Nigeria Centre for Disease Control and Prevention has said the 62 contacts identified following the confirmation of an imported Ebola case in the country are expected to complete monitoring by November 13, 2026.
